INTRODUCTION AND OBJECTIVES: Metastatic penile squamous cell carcinoma (mPSCC) is associated with poor survival due to the molecular mechanism of proliferation and metastasis stay unclear. For this reason,we have performed the whole-genome microarrays analysis in 12 mPSCC patients with matched primary,metastasis and normal pairs to explore the expression difference in this rare malignancy.
METHODS: A total of 36 clinically matched specimens are divided into normal tissue group (N), penile primary carcinoma group (PCA) and lymph node metastasis group (LM) respectively. After eliminating the non-compliant paired samples owing to RNA degradation,we have performed comprehensive genome microarrays by Affymetirx and establish a mPSCC gene expression model. Each gene expression is detected by the illuminated intensity of the probe and calculate the value of fold changes(FC) between two groups(PCA vs N group and LM vs N group). FC>2 and false discover rate <0.05 is the screening criteria in gene with distinctive expression.Genes with higher expression levels in M than PCA are verified by RT-qPCR and HCS cell proliferation screening experiments. Lastly, the potential genes which have an radical influence on proliferation or metastasis are validated by in vivo and in vitro experiments.
RESULTS: 8 in 12 mPSCC patients' paired samples with high quality used to establish the whole-genome expression model. There are 108 genes with over expression and 327 genes in downregulated both in PCA and LM group. Among them, 57 genes express higher in LM than PCA. HCS cell proliferation screening experiments prove that shRAB20, shAIM2, and shBCL2A1 inhibit cell proliferation with the ratio of 1.95, 1.73 and 1.61 respectively, compared with shCtrl group.
CONCLUSIONS: RAB20, AIM2, and BCL2A1 genes are highly correlated with the proliferation of the mPSCC and its metastatic potential needs further confirmation.
Source of Funding: none

MP73-18 IDENTIFYING FACTORS WHICH PROLONG LENGTH OF STAY FOLLOWING OPEN RETROPERITONEAL LYMPH NODE DISSECTION
Adam Pearce*, Jessica Whibley, Susanna Walker, Erik Mayer, David Nicol, London, United Kingdom
INTRODUCTION AND OBJECTIVES: Enhanced Recovery
After Surgery (ERAS) is an evidence-based approach to help patients recover faster following major surgery. It is now standard practice following many operations in most hospitals. Retroperitoneal lymph node dissection (RPLND) is a complex operation, requiring mobilisation of the colon and small bowel mesentery to access the retroperitoneum. Whilst the mean age at surgery is just 35, surgery in most patients is preceded by multi-agent chemotherapy regimens. Approximately 10% of patients require an adjuvant nephrectomy, whilst a smaller number require complex vascular procedures or visceral resection. In implementing an ERAS protocol, we sought to identify patient and surgical factors which affect Length of Stay (LoS), to help select patients who are unsuitable for a rapid hospital stay pathway METHODS: We reviewed the LoS for all patients undergoing open RPLND at a single high volume centre between July 2012 and Oct 2018. The following factors were assessed for their effect on length of stay: age, number of prior courses of chemotherapy, operation time, blood loss, requirement for adjuvant procedures or transfusion, epidural analgesia, and post-operative Systemic Inflammatory Response Syndrome (SIRS).
Linear variables were grouped into a maximum of three groups, with a minimum of 50 patients per group where possible. Linear regression analysis and Mann-Whitney test were used to assess significance, with p<0.05 assumed to be statistically significant. RESULTS: Results are summarised in Table 1 . Patients who had surgical time >5 hrs, and required both adjuvant procedures and transfusion had a mean and median length of stay 15.2 and 10 days respectively. Patients who had none of these factors and did not develop a SIRS response had mean and median length of stay 5.71 and 5 days respectively. CONCLUSIONS: We believe that an ERAS pathway should be standard of care for open RPLND. Those that are unsuitable can be rapidly identified by the intra-operative parameters comprising all 3 of an operation time >5 hours and require adjuvant procedures and transfusion. These patients represent just 4.5% of cases, for whom individualised management plans can be rapidly revised including preparation and planning for a longer hospitalisation.
Source of Funding: none
MP73-19 VALIDATION OF PRIMARY TUMOR SURGERY AS A PROGNOSTIC INDICATOR IN SEMINOMA PATIENTS WITH DISTANT METASTASIS AT DIAGNOSIS: A POPULATION-BASED STUDY
Shengming Jin*, Beihe Wang, Weijie Gu, Dingwei Ye, Shanghai, China, People's Republic of INTRODUCTION AND OBJECTIVES: Primary tumor surgery is recommended for patients with seminoma regardless of staging. Our study aims to validate the prognostic value of primary tumor surgery for seminoma patients with distant metastasis at diagnosis.
METHODS: 546 seminoma patients with distant metastasis at diagnosis between 2004 and 2014 were identified from The Surveillance, Epidemiology, and End Results (SEER) database. The prognostic value of primary tumor surgery was assessed by Kaplan-Meier methods, log-rank analyses, and multivariate Cox proportional hazards model. Survival curves and a forest graph were also plotted.
RESULTS: In our study, 455 patients (83.3%) had received a surgery while 91 patients (16.7%) did not. Survival analysis indicated that patients who underwent a surgery had a better 5-year overall survival (OS, 67.0%vs86.6%, P<0.001) and cancer-specific survival (CSS, 72.5%vs89.9%, P<0.001) than those who did not. Multivariate analyses demonstrated that Primary tumor surgery was an independent prognostic factor for OS (HR:0.369, P[0.030) and CSS (HR: 0.287, 95%CI: 0.100-0.822, P[0.020), along with age at diagnosis, M stage and marital status. Besides, Primary tumor surgery still had considerable prognostic value for OS (N1:P<0.001, Nx:P[0.136) and CSS (N1:P<0.001, N2-3:P[0.019, Nx:P[0.074) in subgroup analysis of patients with lymph node metastasis.
CONCLUSIONS: Our study validated that Primary tumor surgery was correlated with improved survival in seminoma patients with distant metastasis. Furthermore, primary tumor surgery is an independent prognostic indicator for seminoma patients with distant metastasis.
Source of Funding: None
MP73-20 PREDICTORS OF SURGICAL REFERRAL FOR RECONSTRUCTION IN PATIENTS UNDERGOING MOHS SURGERY FOR SQUAMOUS CELL CARCINOMA OF THE MALE GENITALIA
Alexander Skokan*, Raju Chelluri, Leilei Xia, Matthew Heavner, Ibardo Zambrano, Christopher Miller, Robert Caleb Kovell, Philadelphia, PA INTRODUCTION AND OBJECTIVES: For low risk penile squamous cell carcinoma (SCC) and carcinoma in situ (CIS), there are many options for management with little data to drive shared decisionmaking about outcomes with each approach. The need for staged surgery with genital reconstruction in some cases adds potential morbidity after oncologic resection. We hypothesize that clinical tumor characteristics would be predictive of surgeon involvement in complex reconstruction or closure after Mohs resection.
METHODS: A retrospective review was conducted of a pro
